{
    "nctId": "NCT05544123",
    "briefTitle": "The Treatment Situation of Chinese County Population With Breast Cancer",
    "officialTitle": "A Multi-center, Observational Study to Describe the Treatment Situation of Chinese County Population With HER2+ & HR+/HER2- Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Breast Carcinoma, Breast Tumor",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 2500,
    "primaryOutcomeMeasure": "the treatment pattern in HER2+, and HR+HER2- early and advanced breast cancer patients in county in each cohort",
    "eligibilityCriteria": "Inclusion Criteria:\n\nCohort 1\n\n* Age \u2265 18 years at the time of enrollment\n* Histologically confirmed HER2+ breast cancer\n* Newly diagnosed or completed definitive early breast surgery\n* Complete medical history information\n\nCohort 2\n\n* Age \u2265 18 years at the time of enrollment\n* Histologically confirmed HR+ HER2- breast cancer\n* Newly diagnosed or completed definitive early breast surgery\n* Complete medical history information\n\nCohort 3\n\n* Age \u2265 18 years at the time of enrollment\n* Histologically confirmed HER2+ breast cancer\n* De Novo or recurrent metastatic breast cancer\n* Complete medical history information\n\nCohort 4\n\n* Age \u2265 18 years at the time of enrollment\n* Histologically confirmed HR+ HER2- breast cancer\n* De Novo or recurrent metastatic breast cancer\n* Complete medical history information\n\nExclusion Criteria:\n\nCohort 1\n\n* Participated in other Intervention drug clinical trials within 4 weeks before admission Cohort 2\n* Participated in other Intervention drug clinical trials within 4 weeks before admission Cohort 3\n* Patients with HER2 + advanced breast cancer who have received more than 2 lines of therapy\n* Participated in other Intervention drug clinical trials within 4 weeks before admission Cohort 4\n* Patients with HR+ HER2- advanced breast cancer who have received more than 2 lines of therapy\n* Participated in other Intervention drug clinical trials within 4 weeks before admission",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}